Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Low vitamin D levels may cause hair loss in women.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Early treatment is important for better hair regrowth in elderly women with hair loss.

A woman had temporary hair loss due to a stress-related condition after a facelift.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

People with chronic hair shedding had much lower vitamin D levels compared to healthy people.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Iron deficiency is linked to hair loss in CTE patients.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.